Vexim received approval in Australia to market SpineJack® and the Masterflow™ cement delivery system. Product is slated for initial export within 2016.
Bioretec’s Activa implants, designed for fracture repair, arthrodesis, etc., reached the milestone of 100,000 patients operated over 10 years, with a complication rate of 0.01%.
Ferring Pharmaceuticals acquired exclusive development and commercialization rights to Seikagaku’s SI-6603 injectable condoliase, a potential treatment for lumbar disc herniation, for up to US $95.0MM in upfront cash plus milestone payments.
KFx Medical was awarded a third patent (U.S. Patent No. 9,414,835) for self-punching/self-tapping orthopaedic anchors, designed to eliminate the need to drill a hole prior to insertion.
CTL Medical entered into a General Services Administration partnership with Firehouse Medical to sell spinal implants and devices to the U.S. government.Â